🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective of the study is to compare sacituzumab tirumotecan co...
Status
Recruiting
Location
Mayo Clinic in Arizona - Phoenix ( Site 0147)
Start Date
2023-12-15
Trial ID
NCT06170788
Treatments Being Tested
The purpose of this study is to evaluate sacituzumab tirumotecan versus pem...
Status
Active Not Recruiting
Location
Kaiser Permanente - Oakland ( Site 0054)
Start Date
2024-06-11
Trial ID
NCT06305754
This is a single-arm, single-center, exploratory clinical study. The study ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-05-01
Trial ID
NCT07579598
Treatments Being Tested
This study will compare how safe and effective sacituzumab tirumotecan is v...
Status
Active Not Recruiting
Location
Banner MD Anderson Cancer Center ( Site 0119)
Start Date
2024-05-03
Trial ID
NCT06356311
Researchers are looking for new ways to treat people with endometrial cance...
Status
Active Not Recruiting
Location
USA Mitchell Cancer Institute ( Site 4142)
Start Date
2023-12-06
Trial ID
NCT06132958
Treatments Being Tested
Researchers are looking for new ways to treat esophageal squamous cell carc...
Status
Recruiting
Location
UPMC Hillman Cancer Center ( Site 1904)
Start Date
2025-07-30
Trial ID
NCT06780111
The main goals are after treatment given before surgery, to measure the num...
Status
Recruiting
Location
Southern Cancer Center (SCC) ( Site 8004)
Start Date
2025-03-20
Trial ID
NCT06788912
Researchers are looking for new ways to treat certain types of advanced sol...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-09-30
Trial ID
NCT07785609
Researchers are looking for new ways to treat people with proficient mismat...
Status
Recruiting
Location
University of South Alabama, Mitchell Cancer Institute ( Site 6033)
Start Date
2025-05-22
Trial ID
NCT06952504
Treatments Being Tested
Researchers want to learn if sacituzumab tirumotecan (MK-2870) alone or wit...
Status
Recruiting
Location
UCLA ( Site 0317)
Start Date
2024-06-20
Trial ID
NCT06428409